Table 1.

Peripheral miRNAs levels in the study groups

	COVID-19-negative control			Asymptomatic IgG-positive COVID-19				Critical COVID-19 patients
	Median	Q1	Q3	Median	Q1		Q3	p value versus COVID-19-negative controls	Median	Q1	Q3	p value versus COVID-19-negative controls	p value versus aymptomatic IgG positive patients
hsa-miR-32-5p	5.359	5.161	5.444	5.186	4.677	5.324		0.1616	5.356	5.191	5.789	>0.9999	0.0330
hsa-miR-98-3p	3.201	2.905	3.362	3.377	3.087	3.624		0.2258	3.469	3.269	3.815	0.0254	>0.9999
hsa-miR-214-3p	3.869	3.737	4.125	3.793	3.534	4.164		>0.999	3.756	3.525	3.926	0.8096	>0.9999
hsa-miR-421	4.037	3.919	4.137	4.113	4.059	4.257		0.4034	4.148	4.074	4.361	0.1692	>0.9999
hsa-miR-423-3p	4.961	4.842	5.048	5.094	5.037	5.181		0.1207	5.192	4.969	5.289	0.0048	0.7860
hsa-miR-1246	5.343	5.155	5.583	5.361	5.121	5.605		>0.9999	6.009	5.695	6.846	0.0007	0.0005

Data presented as median (Q1-Q3). Coefficient significant at p < 0.05 (highlighed in bold).